Parmax Pharma Limited (PARMAX.BO)

INR 46.0

(4.93%)

Annual Cash Flows

(In INR)
Breakdown 2023 2022 2021 2020
Operating Cash Flow 3.33 Million 7.49 Million 35.25 Million 28.24 Million
Net Income 461.23 Thousand 3.03 Million 12.08 Million 7.3 Million
Depreciation & Amortization 18.78 Million 19.32 Million 19.41 Million 10.07 Million
Deferred income taxes - - - -
Stock-based compensation - - - -
Change in working capital -14.05 Million -12.7 Million 6.7 Million 12.37 Million
Other non-cash items -2 Million - - -
Investing Cash Flow -9.36 Million -15.31 Million -31.45 Million -23.99 Million
Investments in PPE -9.36 Million -15.31 Million -31.45 Million -23.99 Million
Acquisitions - - - -
Investment purchases - - - -
Sales/Maturities of investments - - - -
Other Investing Activities - - - -
Financing Cash Flow -441.57 Thousand -9.1 Million 3.99 Million -2.25 Million
Debt repayment -441.57 Thousand -9.1 Million -3.99 Million -2.25 Million
Dividends payments - - - -
Common Stock Repurchased - - - -
Common Stock Issuance - - - -
Other Financing Activities - - - -
Accounts receivables -1.55 Million - - -
Accounts payables - - - -
Inventory -14.53 Million 11 Million -12.29 Million 12.45 Million
Other working capital 2.18 Million - - -
Cash at beginning of period 10.54 Million 27.46 Million 19.67 Million 15.67 Million
Cash at end of period 4.06 Million 10.54 Million 27.46 Million 17.67 Million
Capital Expenditure -9.36 Million -15.31 Million -31.45 Million -23.99 Million
Effect of forex changes on cash - - - -
Net cash flow / Change in cash -6.47 Million -16.92 Million 7.78 Million 2 Million
Free Cash Flow -6.03 Million -7.82 Million 3.79 Million 4.25 Million

Cash Flow Charts